Evidence map›Paper›PMID 31157105›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2019

Therapeutic drug monitoring of antibiotic agents: evaluation of predictive performance.

Martin Šíma, Hana Bakhouche, Jan Hartinger, Tereza Cikánková, Ondřej Slanař

Abstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Martin ŠímaDepartment of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Hana BakhoucheDepartment of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Jan HartingerDepartment of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Tereza CikánkováDepartment of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.
Ondřej SlanařDepartment of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Praha, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe precision of the population pharmacokinetic model used in therapeutic drug monitoring (TDM) is essential for successful dosage optimisation.

objectiveTo evaluate the predictive performance of pharmacokinetic models used in our hospital and to evaluate the possible impact of demographic characteristics or renal function on TDM accuracy.

methodsWe compared a posteriori an adjusted concentration-time curve profile based on the first measured drug concentration with the second measured drug concentration. Linear regression models were used to compare predicted and observed drug serum concentrations, and to evaluate potential relationships between predictive performance and patients´ demographic/clinical features. Predictive performance of TDM was expressed using accuracy, precision, sensitivity and specificity.

resultsOne hundred and fifty-two patients were enrolled in the study. All pharmacokinetic models showed good predictive performance expressed by the coefficient of determination (r

conclusionWe found the predictive performance of both aminoglycosides and vancomycin pharmacokinetic models to be satisfactory.

Indexed as

amikacinaminoglycosidesgentamicinpharmacokineticstherapeutic drug monitoringvancomycin

Identifiers

PMID31157105
PMCPMC6452355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.